Brief: Elicera Therapeutics Q4 Oper Loss Narrows To SEK 2.9 Mln
Feb 3 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* Q4 LOSS FOR PERIOD AMOUNTED TO SEK -2,603,242 (-4,749,222)
* Q4 OPERATING LOSS AMOUNTED TO SEK -2,911,958 (-5,212,694)
Source text: ID:nWkr2rsldY
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application